azx100
Peptideexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00811577)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- azx100
- azx100
- azx 100
- azx-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00892723 | Phase 2 | May 1, 2009 | Capstone Therapeutics |
| NCT00825916 | Phase 2 | Mar 1, 2009 | Capstone Therapeutics |
| NCT00811577 | Phase 2 | Jan 1, 2009 | Capstone Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capstone Therapeutics | For profit | 3 | 3 | 1 | 2009 |
1 organizations
Page 1 / 1